TKNOAlpha Teknova Inc. Common Stock
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary …
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Older | ||
 Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference Alpha Teknova (NASDAQ:TKNO) Chief Financial Officer Matt Lowell said the provider of laboratory and bioprocessing reagents is seeing renewed growth, reporting record second-quarter revenue and raising its full-year outlook as biopharma funding and life-science end markets improve. Speaking at the S | ||
 Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy? Does Alpha Teknova (TKNO) have what it takes to be a top stock pick for momentum investors? Let's find out. | ||
 Wall Street Analysts Believe Alpha Teknova (TKNO) Could Rally 35.45%: Here's is How to Trade The mean of analysts' price targets for Alpha Teknova (TKNO) points to a 35.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. | ||
 Alpha Teknova (TKNO) Stock Moves Higher on Booming Clinical Demand Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […] | IInsider Monkey | |
 Alpha Teknova Q2 Earnings Call Highlights Alpha Teknova (NASDAQ:TKNO) reported second-quarter revenue growth of 18% from a year earlier, surpassing $12 million for its highest quarterly revenue in the company’s 30-year history. The company raised its full-year revenue outlook, citing first-half performance and confidence in the second half | ||
Alpha Teknova Inc (TKNO) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ... Alpha Teknova Inc (TKNO) posts highest quarterly revenue in company history, up 18% year-over-year, and lifts full-year 2026 outlook to $45-$47 million. | ||
 Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls | TThe Fly | |